// App-Quantinova.ai

2021 : Favorable Outcomes of Autologous Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Remission: On Behalf of the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

Researchers

Presenter

  • Takakazu Kawase

Principal Investigators

  • Shinichi Kako

  • Junji Tanaka

  • Shuichi Mizuta

  • Kazuteru Ohashi

  • Mineo Kurokawa

  • Koji Iwato

  • Takehiko Mori

  • Ritsuro Suzuki

  • Hisashi Sakamaki

  • Yasuo Morishima

Medical Centers

  • Department of HSCT Data Management/Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan

  • Department of Human Genetics, Graduate School of Medicine- University of Tokyo, Japan

  • Division of Medical Oncology, Showa University School of Medicine, Tokyo, Japan

  • Department of Surgery, Saitama Medical Center, Jichi Medical University, Saitama, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

  • Department of Respiratory Disease, Hiroshima Red Cross & Atomic-bomb Survivors Hospiral, Hiroshima, Japan

  • Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan

  • Department of Neurosurgery, Fujita Health University, Toyoake, Japan

  • Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan

  • Department of Gastroenterology and Hepatology, Hokkaido University Hospital, japan, Sapporo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • White Blood Cell

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved